▁The 10.375
▁British 6.01953125
▁bi 11.609375
ote 3.251953125
ch 2.013671875
▁firm 7.01171875
, 2.6484375
▁Ac 8.953125
me 5.296875
▁Ph 4.64453125
arma 0.1729736328125
ce 3.8828125
ut 5.92578125
ical 0.190673828125
s 4.65625
, 1.244140625
▁has 4.73828125
▁announced 3.078125
▁that 1.5234375
▁its 2.923828125
▁new 3.107421875
▁cancer 6.23828125
▁drug 3.1328125
▁has 2.681640625
▁shown 4.0
▁prom 4.47265625
ising 0.025054931640625
▁results 1.017578125
▁in 1.701171875
▁early 3.935546875
▁clin 1.6708984375
ical 0.01465606689453125
▁tri 0.58203125
als 0.0004773139953613281
. 1.0771484375
▁However 5.90234375
, 0.055511474609375
▁anal 7.859375
yst 0.10491943359375
s 0.07061767578125
▁are 1.8291015625
▁ur 5.421875
ging 0.04095458984375
▁ca 0.386474609375
ution 0.0010290145874023438
▁as 2.3125
▁more 3.849609375
▁testing 3.833984375
▁is 0.6171875
▁needed 0.74169921875
▁to 1.5078125
▁determine 1.8740234375
▁its 1.7861328125
▁effect 2.3515625
iveness 0.0200347900390625
▁and 2.03515625
▁potential 3.01171875
▁side 0.80712890625
▁effects 0.2392578125
. 0.22216796875
<0x0A> 1.04296875
The 1.8896484375
▁drug 1.72265625
, 1.251953125
▁named 4.01953125
▁AC 4.26171875
ME 3.873046875
- 0.84521484375
1 0.89599609375
2 2.453125
3 2.798828125
, 0.5146484375
▁is 0.5966796875
▁designed 2.337890625
▁to 0.0460205078125
▁target 2.75390625
▁a 2.08984375
▁specific 1.3779296875
▁protein 1.3544921875
▁found 3.705078125
▁in 0.39892578125
▁certain 3.330078125
▁types 0.96240234375
▁of 0.0022144317626953125
▁cancer 0.716796875
▁cells 1.08203125
. 0.71826171875
▁According 3.48046875
▁to 0.0016298294067382812
▁Ac 3.580078125
me 0.00357818603515625
▁Ph 0.59521484375
arma 0.0022678375244140625
ce 0.07061767578125
ut 0.0003590583801269531
ical 0.0003020763397216797
s 0.031463623046875
, 0.168212890625
▁the 0.50341796875
▁drug 0.268798828125
▁has 1.8408203125
▁been 2.515625
▁successful 5.609375
▁in 0.07275390625
▁in 2.8359375
hib 0.11163330078125
iting 0.001682281494140625
▁the 0.38720703125
▁growth 0.68115234375
▁of 0.17578125
▁cancer 0.9990234375
▁cells 0.1358642578125
▁and 2.08984375
▁indu 4.87109375
cing 0.0074005126953125
▁cell 1.90234375
▁death 0.05615234375
▁in 0.7568359375
▁labor 5.19140625
atory 0.0021686553955078125
▁tests 0.9296875
▁and 5.0234375
▁early 1.873046875
- 3.466796875
stage 0.135009765625
▁clin 0.1234130859375
ical 0.00020766258239746094
▁tri 0.06365966796875
als 4.5299530029296875e-06
. 0.060455322265625
<0x0A> 0.93603515625
The 1.205078125
▁tri 7.57421875
als 0.0008816719055175781
▁involved 3.404296875
▁a 2.2265625
▁small 2.455078125
▁group 0.73681640625
▁of 0.0017795562744140625
▁patients 0.64208984375
▁with 0.333740234375
▁various 2.578125
▁types 0.2646484375
▁of 0.00495147705078125
▁cancer 0.1541748046875
, 0.6904296875
▁including 0.369384765625
▁lung 2.3984375
, 0.50341796875
▁breast 0.87939453125
, 0.2059326171875
▁and 0.7265625
▁colon 2.181640625
▁cancer 0.57568359375
. 0.1673583984375
▁In 2.796875
▁these 2.595703125
▁tri 0.70654296875
als 3.933906555175781e-06
, 0.00678253173828125
▁AC 3.216796875
ME 0.0001138448715209961
- 0.0604248046875
1 0.002140045166015625
2 0.0022182464599609375
3 0.0013360977172851562
▁was 0.39453125
▁admin 1.791015625
ister 0.00015461444854736328
ed 1.3470649719238281e-05
▁or 1.8017578125
ally 0.0011157989501953125
▁in 2.404296875
▁combination 2.28515625
▁with 0.0016918182373046875
▁other 1.720703125
▁chem 1.9853515625
other 0.01971435546875
apy 0.343017578125
▁dru 0.1395263671875
gs 1.1920928955078125e-06
. 0.47900390625
▁The 1.1474609375
▁results 0.9765625
▁showed 1.64453125
▁prom 2.65234375
ising 1.8715858459472656e-05
▁redu 7.98828125
ctions 3.0875205993652344e-05
▁in 0.007305145263671875
▁tum 0.426513671875
or 0.0340576171875
▁size 0.58154296875
▁and 0.3720703125
▁improved 2.5234375
▁patient 3.515625
▁out 2.53125
comes 0.01110076904296875
. 0.343994140625
<0x0A> 0.364990234375
However 0.8837890625
, 0.00036215782165527344
▁anal 2.919921875
yst 0.0008282661437988281
s 0.001277923583984375
▁warn 2.958984375
▁that 0.1964111328125
▁this 4.9921875
▁is 1.40625
▁just 1.3740234375
▁the 0.626953125
▁beginning 0.391357421875
▁of 0.45361328125
▁a 1.4052734375
▁long 0.469970703125
▁process 1.810546875
, 2.51953125
▁and 0.25439453125
▁it 2.990234375
▁remains 2.81640625
▁unclear 3.0234375
▁whether 1.05859375
▁AC 0.5224609375
ME 4.9233436584472656e-05
- 0.0209503173828125
1 0.0010633468627929688
2 0.0016775131225585938
3 0.0004410743713378906
▁will 0.341796875
▁prove 3.04296875
▁to 0.5068359375
▁be 0.007198333740234375
▁a 1.646484375
▁break 4.203125
through 0.0007495880126953125
▁treatment 1.3291015625
▁for 0.2296142578125
▁cancer 0.32373046875
▁or 2.8984375
▁just 2.423828125
▁another 0.28857421875
▁drug 2.15234375
▁that 1.1767578125
▁doesn 3.6015625
' 0.0009131431579589844
t 6.949901580810547e-05
▁pass 8.7421875
▁the 0.80078125
▁rig 4.3828125
orous 0.0160064697265625
▁testing 0.76953125
▁process 2.498046875
. 0.51806640625
▁Many 5.28515625
▁dru 6.046875
gs 7.450580596923828e-05
▁that 1.6572265625
▁have 0.912109375
▁shown 1.748046875
▁promise 0.58056640625
▁in 0.09088134765625
▁early 0.42919921875
▁tri 1.64453125
als 8.702278137207031e-06
▁have 1.06640625
▁failed 1.2939453125
▁in 1.353515625
▁larger 2.82421875
, 2.796875
▁more 0.268798828125
▁compreh 2.24609375
ensive 5.805492401123047e-05
▁studies 0.943359375
. 0.32421875
<0x0A> 0.20263671875
“ 26.21875
Wh 8.109375
ile 0.1141357421875
▁the 1.1982421875
▁early 2.865234375
▁results 0.431396484375
▁of 2.0703125
▁AC 1.49609375
ME 7.128715515136719e-05
- 0.1727294921875
1 0.0020122528076171875
2 0.003383636474609375
3 0.0010662078857421875
▁are 0.288330078125
▁certainly 6.640625
▁encourag 1.0771484375
ing 5.161762237548828e-05
, 0.0207366943359375
▁there 2.4453125
▁is 0.68798828125
▁still 0.378662109375
▁a 0.5361328125
▁long 0.751953125
▁way 0.241455078125
▁to 0.0159149169921875
▁go 0.0006880760192871094
▁before 0.1417236328125
▁we 2.216796875
▁can 0.791015625
▁say 1.0693359375
▁whether 2.326171875
▁this 0.92333984375
▁drug 0.367919921875
▁will 0.65380859375
▁be 0.77685546875
▁effective 1.2958984375
▁in 0.77734375
▁tre 0.51611328125
ating 1.2516975402832031e-05
▁cancer 0.2476806640625
▁patients 1.3798828125
,” 25.21875
▁said 10.859375
▁Dr 4.125
. 0.106201171875
▁John 4.10546875
▁Smith 7.83984375
, 0.26318359375
▁an 2.029296875
▁on 0.1929931640625
colog 0.0224456787109375
ist 0.0038433074951171875
▁at 0.67236328125
▁Harvard 5.2421875
▁Medical 0.2181396484375
▁School 0.0194244384765625
. 0.970703125
<0x0A> 1.1474609375
Ac 5.40625
me 0.00588226318359375
▁Ph 0.1099853515625
arma 0.002826690673828125
ce 0.0087738037109375
ut 0.00023281574249267578
ical 0.000789642333984375
s 0.021881103515625
▁has 1.796875
▁stated 4.71875
▁that 0.045440673828125
▁it 1.36328125
▁will 1.2138671875
▁continue 0.6279296875
▁to 0.15771484375
▁test 3.400390625
▁the 0.94189453125
▁drug 0.13818359375
▁on 3.220703125
▁a 2.00390625
▁larger 1.1171875
▁group 1.310546875
▁of 0.002170562744140625
▁patients 0.300048828125
▁in 1.4189453125
▁advanced 7.640625
- 3.037109375
stage 0.09649658203125
▁clin 0.11920166015625
ical 0.00013399124145507812
▁tri 0.0116729736328125
als 1.430511474609375e-06
. 0.75
▁These 3.85546875
▁tri 0.396240234375
als 1.1920928955078125e-06
▁will 0.413330078125
▁assess 3.74609375
▁the 0.31298828125
▁drug 0.70263671875
' 0.0240478515625
s 0.005306243896484375
▁safety 1.6298828125
▁and 0.1588134765625
▁effect 0.87939453125
iveness 0.002834320068359375
▁over 5.9453125
▁a 0.56640625
▁longer 0.09967041015625
▁period 0.11309814453125
▁of 0.0352783203125
▁time 0.0010080337524414062
▁and 1.8828125
▁in 2.470703125
▁a 1.5947265625
▁more 2.083984375
▁diverse 0.6044921875
▁group 1.7646484375
▁of 0.0015497207641601562
▁patients 0.317138671875
. 0.31982421875
<0x0A> 0.340087890625
The 1.67578125
▁success 4.98828125
▁of 0.09783935546875
▁AC 1.861328125
ME 8.90493392944336e-05
- 0.0160675048828125
1 0.0017147064208984375
2 0.0013074874877929688
3 0.0005817413330078125
▁is 1.244140625
▁of 6.4140625
▁great 0.71630859375
▁importance 1.107421875
▁to 0.56494140625
▁the 1.12109375
▁bi 3.431640625
ote 0.07568359375
ch 0.45703125
▁industry 0.29833984375
, 0.908203125
▁which 1.1591796875
▁has 0.58837890625
▁been 1.185546875
▁struggling 1.046875
▁to 0.418701171875
▁develop 1.4375
▁effective 1.9697265625
▁cancer 1.466796875
▁dru 1.0634765625
gs 6.079673767089844e-06
. 1.26953125
▁Can 7.1875
cer 0.02471923828125
▁remains 3.646484375
▁one 1.333984375
▁of 0.000995635986328125
▁the 0.0042572021484375
▁leading 0.841796875
▁causes 0.039886474609375
▁of 0.0011844635009765625
▁death 0.030029296875
▁world 0.79150390625
wide 0.0009183883666992188
, 0.192626953125
▁with 1.453125
▁over 2.009765625
▁ 0.062286376953125
9 1.7158203125
. 1.251953125
6 1.197265625
▁million 0.004947662353515625
▁death 1.8544921875
s 0.0011119842529296875
▁reported 2.7421875
▁in 0.252685546875
▁ 0.00995635986328125
2 0.00069427490234375
0 3.2782554626464844e-05
1 0.28369140625
8 1.5498046875
. 0.5595703125
<0x0A> 0.66259765625
More 4.84765625
over 1.4697265625
, 0.0021038055419921875
▁cancer 2.0234375
▁dru 2.583984375
gs 9.417533874511719e-06
▁are 0.9462890625
▁not 3.255859375
or 1.1123046875
iously 2.1576881408691406e-05
▁difficult 1.3525390625
▁to 0.010650634765625
▁develop 0.16357421875
▁as 5.30078125
▁they 0.37255859375
▁must 1.5751953125
▁target 4.5390625
▁cancer 4.6171875
▁cells 0.06353759765625
▁without 2.7734375
▁harm 0.60107421875
ing 0.0026454925537109375
▁health 0.403564453125
y 6.127357482910156e-05
▁ones 2.1640625
. 0.1646728515625
▁Many 3.779296875
▁dru 1.7880859375
gs 2.1576881408691406e-05
▁that 1.4150390625
▁show 4.5546875
▁promise 0.15478515625
▁in 0.05694580078125
▁early 0.264892578125
▁tri 1.3466796875
als 7.867813110351562e-06
▁do 2.919921875
▁not 0.01354217529296875
▁make 3.076171875
▁it 0.058135986328125
▁to 0.84375
▁the 1.271484375
▁market 0.1717529296875
▁due 1.111328125
▁to 0.0013399124145507812
▁un 3.53515625
for 1.5146484375
ese 0.009674072265625
en 0.00788116455078125
▁side 0.187255859375
▁effects 0.0167388916015625
. 1.58984375
<0x0A> 0.377197265625
Ac 3.40625
me 0.0019388198852539062
▁Ph 0.042388916015625
arma 0.0008487701416015625
ce 0.00428009033203125
ut 7.283687591552734e-05
ical 0.0002758502960205078
s 0.00885772705078125
▁is 1.4423828125
▁not 4.30859375
▁the 0.28955078125
▁only 0.79345703125
▁company 0.806640625
▁developing 1.87109375
▁cancer 0.99755859375
▁dru 0.11767578125
gs 2.384185791015625e-06
. 0.3798828125
▁In 2.63671875
▁fact 0.70849609375
, 0.0011310577392578125
▁the 2.49609375
▁field 4.3359375
▁is 0.6923828125
▁highly 3.810546875
▁compet 0.0458984375
itive 0.0001608133316040039
▁and 0.75341796875
▁there 1.9541015625
▁are 0.2459716796875
▁many 0.71923828125
▁other 1.5009765625
▁fir 4.23828125
ms 4.220008850097656e-05
▁working 1.541015625
▁on 0.3916015625
▁similar 0.75927734375
▁treat 3.482421875
ments 2.3603439331054688e-05
. 0.145263671875
▁However 1.2939453125
, 0.0005736351013183594
▁the 1.4990234375
▁success 0.8369140625
▁of 0.026275634765625
▁AC 0.2161865234375
ME 3.898143768310547e-05
- 0.00643157958984375
1 0.0010356903076171875
2 0.0004544258117675781
3 0.0002639293670654297
▁could 2.09375
▁be 1.384765625
▁a 0.45263671875
▁significant 2.982421875
▁break 1.3330078125
through 0.0013494491577148438
▁in 1.3349609375
▁the 0.30419921875
▁fight 1.22265625
▁against 0.0028533935546875
▁cancer 0.01117706298828125
. 0.160888671875
<0x0A> 0.135498046875
Des 5.3515625
p 0.031219482421875
ite 0.0003619194030761719
▁this 2.92578125
, 0.99755859375
▁anal 1.197265625
yst 0.00024116039276123047
s 0.0011501312255859375
▁ca 2.71875
ution 0.0011911392211914062
▁against 2.98828125
▁becoming 5.42578125
▁too 0.58740234375
▁optim 0.58740234375
istic 0.0003368854522705078
▁about 0.70654296875
▁the 0.5283203125
▁drug 0.68212890625
' 0.283203125
s 0.004848480224609375
▁potential 0.365966796875
. 0.7255859375
▁There 2.263671875
▁is 0.360595703125
▁still 0.1341552734375
▁a 0.1834716796875
▁great 4.11328125
▁deal 0.0190887451171875
▁of 0.07537841796875
▁work 0.4736328125
▁to 0.1578369140625
▁be 0.07647705078125
▁done 0.000946044921875
▁before 0.30859375
▁AC 0.380859375
ME 1.6450881958007812e-05
- 0.0084381103515625
1 0.0009527206420898438
2 0.0006237030029296875
3 0.00034737586975097656
▁can 0.56884765625
▁be 0.251708984375
▁approved 1.587890625
▁for 0.305419921875
▁use 0.394775390625
▁by 1.9482421875
▁patients 1.0439453125
. 0.31494140625
<0x0A> 0.9248046875
“ 23.890625
Wh 2.65234375
ile 0.035491943359375
▁we 4.8125
▁are 1.552734375
▁excited 2.001953125
▁by 2.7265625
▁the 0.20849609375
▁early 2.11328125
▁results 0.60546875
, 2.390625
▁it 1.58203125
▁is 0.4560546875
▁important 0.239501953125
▁to 0.080322265625
▁remember 0.5126953125
▁that 0.0038280487060546875
▁developing 6.984375
▁cancer 2.5859375
▁dru 0.1002197265625
gs 2.6226043701171875e-06
▁is 0.356201171875
▁a 0.262451171875
▁long 1.4306640625
▁journey 6.5546875
, 2.654296875
▁and 0.2144775390625
▁many 2.6953125
▁challeng 4.93359375
es 0.0021152496337890625
▁still 2.46484375
▁need 2.462890625
▁to 0.0008411407470703125
▁be 8.487701416015625e-05
▁overcome 0.033782958984375
,” 24.9375
▁said 0.58154296875
▁Beck 10.1171875
y 0.1376953125
▁Jones 5.4453125
, 0.07403564453125
▁an 1.9384765625
▁anal 1.57421875
yst 4.6253204345703125e-05
▁at 0.398681640625
▁Morgan 3.466796875
▁Stanley 0.011199951171875
. 0.170166015625
<0x0A> 0.333251953125
The 1.703125
▁next 5.6328125
▁phases 6.21875
▁of 0.048492431640625
▁clin 1.6064453125
ical 0.0001227855682373047
▁tri 0.1715087890625
als 4.7087669372558594e-05
▁for 3.498046875
▁AC 0.21240234375
ME 3.0279159545898438e-05
- 0.0199737548828125
1 0.0011720657348632812
2 0.0007677078247070312
3 0.0005297660827636719
▁are 1.9765625
▁expected 0.93115234375
▁to 0.0068511962890625
▁take 2.58984375
▁several 1.6435546875
▁years 0.38623046875
▁to 0.98291015625
▁complete 0.022979736328125
. 1.0009765625
▁Only 5.3671875
▁then 0.64501953125
▁will 0.45751953125
▁we 0.2476806640625
▁have 2.388671875
▁a 0.417236328125
▁better 0.489013671875
▁idea 1.0625
▁of 0.10467529296875
▁whether 0.9375
▁this 1.0068359375
▁drug 0.168701171875
▁can 1.4326171875
▁provide 3.12109375
▁real 2.939453125
▁hope 5.81640625
▁for 0.448974609375
▁cancer 0.7109375
▁patients 0.0034618377685546875
. 0.453369140625
▁For 4.34765625
▁now 0.07110595703125
, 0.0028553009033203125
▁the 2.236328125
▁industry 4.765625
▁is 1.1181640625
▁watching 2.611328125
▁closely 0.6767578125
▁and 3.34765625
▁c 8.2734375
aut 0.0006580352783203125
iously 0.004924774169921875
▁optim 2.580078125
istic 0.00247955322265625
▁about 0.87255859375
▁what 2.42578125
▁the 1.3486328125
▁future 0.050323486328125
▁holds 0.3154296875
. 1.2177734375
